alexa

GET THE APP

Prevalence of Multi-Drug Resistant Tuberculosis among New Culture-Positive Pulmonary Tuberculosis Patients in Tertiary Care Center of North India | OMICS International| Abstract

Journal of Tuberculosis and Therapeutics
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Research Article   
  • J Tuberc Ther 2017, Vol 3(2): 116

Prevalence of Multi-Drug Resistant Tuberculosis among New Culture-Positive Pulmonary Tuberculosis Patients in Tertiary Care Center of North India

Sanjeev Sinha1*, Kartik Gupta1, Mikashmi Kohli1, VP Myneedu2, RM Pandey3 and PP Singh4
1Department of Medicine, All India Institute of Medical Sciences, , New Delhi, India
2National Institute of TB and Respiratory Diseases, , New Delhi, India
3Department of Biostatistics, All India Institute of Medical Sciences, , New Delhi, India
4NIPER, Mohali, Punjab, , India
*Corresponding Author : Sanjeev Sinha, Department of Medicine, AIIMS, New Delhi, P.O. Box 110029, India, Tel: +919810164416; 011-26594440, Fax: 011-26588918, Email: [email protected]

Received Date: Feb 09, 2018 / Accepted Date: Mar 30, 2018 / Published Date: Apr 06, 2018

Abstract

Introduction: As India aims to end Tuberculosis (TB) by 2025, increased prevalence of Multi-Drug Resistant (MDR) strains continues to be a major public health concern.

Methods: New case of Pulmonary TB (PTB) was defined as no history of Anti-Tuberculosis Therapy (ATT) intake in the past or taken ATT for <1 month. Single sputum specimen from 1103 suspected PTB cases was collected at two tertiary care referral centers in North India. All samples were subjected to Ziehl-Neelsen stain, culture using
automated BACTEC MGIT™ 960™ and Drug Susceptibility Testing using Line Probe Assay. Resistance testing for Rifampicin and Isoniazid was done in all culture-positive patients.

Results: Of the total 1108 patients (Median Age 34 years, 59% and 41% males and females respectively), there were 683 new PTB cases with liquid culture positive. From these patients, 62 (9.1%) were resistant to rifampicin, 75 were resistant to isoniazid (11%) and 60 (8.7%) patients were resistant to both drugs.

Conclusion: There is a high burden of MDR strains among new PTB cases. A higher than national MDR prevalence (2.8%) could be because both centers were referral institutes. There is an urgent need for universal drug sensitivity testing to escalate detection and treatment of this subgroup of patients.

Keywords: MDR-TB; Pulmonary tuberculosis; Drug susceptibility

Citation: Sinha S, Gupta K, Kohli M, Myneedu VP, Pandey RM, et al. (2018) Prevalence of Multi-Drug Resistant Tuberculosis among New Culture- Positive Pulmonary Tuberculosis Patients in Tertiary Care Center of North India. J Tuberc Ther 3: 116.

Copyright: © 2018 Sinha S, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Top